Endonovo Therapeutics Stock Today
| ENDV Stock | USD 0.0007 0.0001 12.50% |
Performance0 of 100
| Odds Of DistressOver 87
|
Endonovo Therapeutics is selling for under 7.0E-4 as of the 2nd of December 2024; that is 12.5 percent decrease since the beginning of the trading day. The stock's lowest day price was 7.0E-4. Endonovo Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Endonovo Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. The company has 194.33 M outstanding shares. More on Endonovo Therapeutics
Moving together with Endonovo Pink Sheet
Moving against Endonovo Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Endonovo Pink Sheet Highlights
| Chairman | Alan Collier |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Endonovo Therapeutics [ENDV] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Endonovo Therapeutics's market, we take the total number of its shares issued and multiply it by Endonovo Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Endonovo Therapeutics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 194.33 M outstanding shares.
Endonovo Therapeutics currently holds about 59.98 K in cash with (986.58 K) of positive cash flow from operations.
Check Endonovo Therapeutics Probability Of Bankruptcy
Ownership AllocationEndonovo Therapeutics holds a total of 194.33 Million outstanding shares. Endonovo Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Endonovo Ownership Details
Endonovo Therapeutics Risk Profiles
| Mean Deviation | 5.86 | |||
| Standard Deviation | 9.9 | |||
| Variance | 97.99 | |||
| Risk Adjusted Performance | (0.04) |
Endonovo Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Endonovo Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.